跳至主要内容
临床试验/CTRI/2023/05/052473
CTRI/2023/05/052473尚未招募2 期

A Randomized Open-Labelled Controlled Clinical Study To Evaluate The Efficacy Of Langhana In The Management Of Amavata With Special Reference To Rheumatoid Arthritis.

Dr Surabhi G B0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects of either gender in the age group of 21 to 60 years. 2.Subjects fulfilling the diagnostic criteria. 3.Subjects willing to give participate with written consent, which is conveyed in the language which the subject can understand. 4.Disease Activity Score 28 (DAS28) < 5.1

排除标准

  • 1.Subjects who are taking medications for Rheumatoid Arthritis.
  • 2.Pregnant and lactating mothers.
  • 3.Subjects with uncontrolled systemic illness like Diabetes mellitus Type 1 & 2, Hypertension and associated with any other systemic diseases or complication.

研究者

发起方
Dr Surabhi G B

相似试验